High levels of SGOT (Serum glutamic-oxaloacetic transaminase) and SGPT (Serum glutamic-pyruvic transaminase) suggest that liver and kidney function impairment might be triggered by tumor invasion [14]. This evidence concerns the gene GOT1 and neoplasm.